Hughes Medical Institute.
Led by world-renowned immunologists such as Qiu Xiang and Judson, everyone awaited the results of the medication in the isolation room.
The Reedman Virus outbreak was now severe, and the circumstances were exceptional. The World Health Organization and the National Centers for Disease Control had issued a notice allowing medical teams researching a specific drug for Reedman Virus to seek consent from the families of conscious patients and directly administer tested nontoxic or mildly toxic drugs to unconscious patients.
This notice was extremely important. It eliminated the need to test new drugs on animals and could greatly shorten the drug development cycle.
All their drugs were now being tested directly on unconscious patients. Without treatment, death was certain. If they were given new drugs, there was still a sliver of hope for recovery.
This was the thirty-second attempt. Every member prayed for success. They had split into eight groups and explored drug research from nine different directions, yet there had still been no major breakthrough.
The Reedman Virus was simply too overbearing.
During an outbreak, aside from mental hallucinations, every other bodily function of the patient became far stronger than that of a healthy person. Yet after half a month, internal bleeding would begin, eventually leading to death.
Other than the modified HX3 Agent, they had found no other solution for the time being.
They were also continuing to study the modified HX3 Agent, but after a month, it could no longer suppress the virus.
When the doctors in the isolation room injected the patient with the new drug, every researcher held their breath. Ten minutes passed, and the patient was still struggling in fear on the bed, babbling nonsense. Disappointment appeared on everyone's faces.
"We failed again."
Another failure cast a shadow over every medical expert.